Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 14/20 | 0.75 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.67 |
| ▸ | TSHR | P16473 | 1/20 | 0.66 |
| ▸ | HTT | P42858 | 1/20 | 0.66 |
| ▸ | CD38 | P28907 | 1/20 | 0.60 |
| ▸ | THRB | P10828 | 2/20 | 0.60 |
| ▸ | BRAF | P15056 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7538225 | 0.99 | EGFR (0.73) | EGFRABCG2TSHRHTTCD38 | |
| SCHEMBL7965118 | 0.86 | EGFR (0.73) | EGFRABCG2TSHRHTTCD38 | |
| SCHEMBL7978491 | 0.86 | EGFR (1.00) | EGFRABCG2TSHRHTTCD38 | |
| SCHEMBL16882281 | 0.85 | EGFR (0.82) | EGFRABCG2TSHRHTTCD38 | |
| SCHEMBL8373657 | 0.84 | EGFR (0.76) | EGFRABCG2TSHRHTTCD38 | |
| SCHEMBL3001623 | 0.80 | EGFR (1.00) | EGFRABCG2TSHRHTTCD38 | |
| SCHEMBL2100607 | 0.80 | EGFR (1.00) | EGFRABCG2TSHRBRAFLMNA | |
| SCHEMBL28159092 | 0.79 | EGFR (0.76) | EGFRABCG2TSHRHTTCD38 | |
| SCHEMBL8644631 | 0.79 | EGFR (0.71) | EGFRABCG2TSHRHTTCD38 | |
| SCHEMBL6837287 | 0.78 | EGFR (1.00) | EGFRABCG2TSHRHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1141298-A | Pyrimidine-fused heterocyclic compound anti-cancer agents | PFIZER (US) | 1997-01-29 | — | — | CN | claimed |
| US-6395733-B1 | ANTICANCER AGENTS; ANTIPROLIFERATIVE AGENTS | PFIZER INC | 2002-05-28 | — | — | US | disclosed |
| EP-0831829-A4 | HETEROCYCLIC RING-FUSED PYRIMIDINE DERIVATIVES | PFIZER (US) | 1998-11-25 | — | — | EP | disclosed |
| EP-0831829-A1 | HETEROCYCLIC RING-FUSED PYRIMIDINE DERIVATIVES | PFIZER INC. (US) | 1998-04-01 | — | — | EP | disclosed |
| CN-1141298-A | Pyrimidine-fused heterocyclic compound anti-cancer agents | PFIZER (US) | 1997-01-29 | — | — | CN | disclosed |
| WO-1996040142-A1 | HETEROCYCLIC RING-FUSED PYRIMIDINE DERIVATIVES | PFIZER INC. (US) | 1996-12-19 | — | — | WO | disclosed |